Health outcomes modelling of RNA-based versus DNA-based detection of driver gene rearrangements in non-small cell lung cancer.
Jun T, Oh W, Schadt E, Higashi M. Health outcomes modelling of RNA-based versus DNA-based detection of driver gene rearrangements in non-small cell lung cancer. Journal Of Clinical Oncology 2022, 40: e18837-e18837. DOI: 10.1200/jco.2022.40.16_suppl.e18837.Peer-Reviewed Original ResearchQuality-adjusted life yearsTargeted therapyLung cancerNTRK1-3Gene rearrangementsLife yearsNon-small cell lung cancerMetastatic NSCLC casesTargeted therapy optionsCell lung cancerPopulation-level prevalence dataRNA-based methodsMetastatic NSCLCMET exonStable diseaseNSCLC casesSequencing panelTherapy optionsDNA-based methodsClinical impactFalse negativesHazard ratioNegative casesFDA approvalTherapy
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply